Skip to main content
NCBI home page
Translational Psychiatry logoLink to Translational Psychiatry
. 2021 Feb 18;11:133. doi: 10.1038/s41398-021-01259-0

Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study

Minghuan Wang 1, Caihong Hu 1, Qian Zhao 1, Renjie Feng 1, Qing Wang 2, Hongbin Cai 2, Zhenli Guo 3, Kang Xu 4, Wenjing Luo 5, Canshou Guo 6, Sheng Zhang 7, Chunfa Chen 8, Chunli Zhu 9, Hongmin Wang 10, Yu Chen 11, Li Ma 12, Peiyan Zhan 13, Jie Cao 1, Shanshan Huang 1, Mia Jiming Yang 14, Yuxin Fang 15, Suiqiang Zhu 1, Yuan Yang 1,✉
PMCID: PMC7890099  PMID: 33602920

Abstract

We conducted a multicentre cross-sectional survey of COVID-19 patients to evaluate the acute psychological impact on the patients with coronavirus disease 2019 (COVID-19) during isolation treatment based on online questionnaires from 2 February to 5 March 2020. A total of 460 COVID-19 patients from 13 medical centers in Hubei province were investigated for their mental health status using online questionnaires (including Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Patient Health Questionnaire-15, and Insomnia Severity Index scales). Among all 460 COVID-19 patients, 187 (40.65%) of them were healthcare workers (HCWs). 297 (64.57%) of them were females. The most common psychological problems were somatization symptoms (66.09%, n = 304), followed by depression (53.48%, n = 246), anxiety (46.30%, n = 213), problems of insomnia (42.01%, n = 171), and then self-mutilating or suicidal thoughts (23.26%, n = 107). Of all the patients, 15.65% (n = 72) had severe somatization symptoms, and 2.83% (n = 13) had severe (almost every day) self-mutilating or suicidal thoughts. The most common psychological problems for HCWs were somatization symptoms (67.84%, n = 125), followed by depression (51.87%, n = 97), anxiety (44.92%, n = 84), problems of insomnia (36.18%, n = 55), and then self-mutilating or suicidal thoughts (20.86%, n = 39). Patients with lower education levels were found to be associated with higher incidence of self-mutilating or suicidal thoughts (odds ratio [OR], 2.68, 95% confidence interval [95% CI], 1.66–4.33 [P < 0.001]). Patients with abnormal body temperature were found to be associated with higher incidence of self-mutilating or suicidal thoughts (OR, 3.97, 95% CI, 2.07–7.63 [P < 0.001]), somatic symptoms (OR, 2.06, 95% CI, 1.20–3.55 [P = 0.009]) and insomnia (OR, 1.66, 95% CI, 1.04–2.65 [P = 0.033]). Those with suspected infected family members displayed a higher prevalence of anxiety than those without infected family members (OR, 1.61, 95% CI, 1.1–2.37 [P = 0.015]). Patients at the age of 18–44 years old had fewer somatic symptoms than those aged over 45 years old (OR, 1.91, 95% CI, 1.3–2.81 [P = 0.001]). In conclusion, COVID-19 patients tended to have a high prevalence of adverse psychological events. Early identification and intervention should be conducted to avoid extreme events such as self-mutilating or suicidal impulsivity for COVID-19 patients, especially for those with low education levels and females who have undergone divorce or bereavement.

Subject terms: Human behaviour, Depression

Introduction

The outbreak of coronavirus disease 2019 (COVID-19) first emerged in Wuhan, Hubei Province, China, in December 20191–4. The pandemic of COVID-19 has led to the declaration of Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) on 30 January 20205. To fight against this emergent infectious disease, drastic measures have been taken, such as closing schools and canceling sporting events and other gatherings6. Many big cities like Wuhan were forced to undergo quarantine to control the transmission of this infectious disease. To make things worse, very few treatments had been proved effective for this disease until recently7–9. People in the swirl of this catastrophic epidemic would inevitably develop varying degrees of anxiety, depression, panic, and insomnia10,11. Healthcare workers (HCWs) were at high risk of infecting COVID-19 owing to insufficient medical supplies at the early stage of the epidemic12,13. It was reported that the infected HCWs accounted for 29% of all hospitalized COVID-19 patients at the beginning of the epidemic14. A multi-national and -center study found that the prevalence of physical symptoms was significantly associated with the adverse psychological outcomes of depression, anxiety, stress, and post-traumatic stress disorder (PTSD) among the HCWs, who were involved in caring for the COVID-19 patients in India and Singapore during the initial stages of COVID-19 pandemic.13 Another Singapore study suggested that the nonmedical HCWs were found under even higher risk in anxiety, stress, and subjective distress caused by traumatic events during the outbreak of the pandemic15.

Studies on the psychological characteristics of quarantined Severe Acute Respiratory Syndrome (SARS) patients revealed that different levels of anxiety, depression, insomnia, and other psychological stress reactions occurred during the SARS outbreak16,17. Quarantined COVID-19 patients including infected HCWs might be facing potential social isolation18–20. Moreover, people became surrounded by negative information and rampant misinformation, which had inevitably exaggerated people’s fear, panic, as well as distress. In such a situation, a range of psychological health problems can be anticipated but have yet to be evaluated21. Therefore, the purpose of this study is to assess the mental health of COVID-19 patients through an online questionnaire and provide a basis for future psychological intervention.

Methods

Study design and participants

This study was a multicenter cross-sectional study. A total of 460 COVID-19 patients from 13 medical centers in Hubei Province participated in this study, covering ~5% of the total hospitalized cases in Hubei province at that time. We used a stratified random sampling method to obtain a representative sample, which proportionated to the number of patients admitted to this hospital. We stratified patients in HCWs and others within each selected hospital and, after that, randomly selected them from each center. We included a substantial number of HCWs in this survey aimed to study the psychological problems of HCWs. The sample size in each hospital was proportionated to the number of patients admitted in this hospital, and at least 30% of them were HCWs. The severity of COVID-19 was determined based on the WHO Interim Guidelines document22. We only included the COVID-19 patients who were not in critical conditions in our survey. The health conditions of patients were evaluated by the physicians of the isolation wards. Only those who were capable of completing the survey were enrolled in the survey.

Data were collected through anonymous online questionnaires using PHQ-9 (Patient Health Questionnaire-9), GAD-7 (Generalized Anxiety Disorder-7), PHQ-15 (Patient Health Questionnaire-15), and ISI (Insomnia Severity Index) scales. Sociodemographic information was also collected through anonymous online questionnaires. The senior investigators performed quality control by checking the collected questionnaires daily. Informed consent was obtained from all subjects and the study was approved by the institutional ethics board of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (ID: TJ-IRB20200101).

Measures

PHQ-9 Scale was used to measure the depression symptoms23,24. A cutoff of ≥5 has been recommended for considering depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. GAD-7 Scale was used to identify anxiety disorders.25 A cutoff score of ≥5 is recommended for considering clinically important anxiety symptoms, which provides adequate sensitivity (82.0%) and specificity (77.0%). GAD-7 scores of 5, 10, and 15 represented mild, moderate, and severe anxiety disorders, respectively. PHQ-15 Scale was used to measure the somatic symptoms severity26. A cutoff of ≥5 has been recommended for considering somatization symptoms, which provides adequate sensitivity (88.0 percent) and specificity (88.0 percent). PHQ-15 scores of 5, 10, and 15 represented mild, moderate, and severe somatic symptoms, respectively. ISI Scale was used to measure the severity of insomnia27. ISI scores of 8, 15, and 22, represented mild, moderate, and severe insomnia, respectively, and previously used during the past COVID-19 research28,29. A cutoff of ≥10 has been recommended for detecting insomnia, which provides adequate specificity (87.7%) and sensitivity (86.1%). Self-mutilating or suicidal thoughts were acquired from the last item of PHQ-9 Scale as “Thoughts that you would be better off dead or of hurting yourself in some way”30.

Statistical analysis

Date was generated from the online survey system. Descriptive statistics of categorical data were expressed by a number of cases and percentage. Multiple logistic regression models were used to explore the risk factors related to psychological problems in COVID-19 patients and HCWs with COVID-19, respectively. This study was a multicentre design. Therefore, the mixed effect model was selected to analyze the data. Considering that the survey data of different research objects in the same medical institution might be aggregated, when building the model, the medical institution was set as a random effect. SPSS19.0 was subsequently used for statistical analysis. P value ≤0.05 was defined as the standard significance level.

Results

A total of 460 COVID-19 patients from 13 medical centers in Hubei provinces were included in our final survey, with a response rate of 92.3% (460/498). Among all COVID-19 patients, 187 (40.65%) of them were HCWs and 297 (64.57%) were females. Most individuals were in the age intervals of 18–44 years old (222 [48.26%]), and 79 (17.17%) were adolescents. In all, 84 (18.26%) patients were living alone. Nearly half of the patients (42.17%) had family members who were infected. Other characteristics of the survey population are shown in Table 1. The distribution of psychological problems and the severity are displayed in Fig. 1. The most common psychological problems were somatization symptoms (66.09%, n = 304), followed by depression (53.48%, n = 246), anxiety (46.30%, n = 213), problems of insomnia (42.01%, n = 171), and then self-mutilating or suicidal thoughts (23.26%, n = 107). Of all, 15.65% (n = 72) patients had severe somatization symptoms; 8.91% patients (n = 41) had severe anxiety; 5.87% (n = 27) patients had severe depression; 2.83% (n = 13) patients had severe self-mutilating or suicidal thoughts; 2.70% (n = 11) patients had severe problems of insomnia. The most common psychological problems for HCWs were somatization symptoms (67.84%, n = 125), followed by depression (51.87%, n = 97), anxiety (44.92%, n = 84), problems of insomnia (36.18%, n = 55), and then self-mutilating or suicidal thoughts (20.86%, n = 39).

Table 1.

Sociodemographic characteristics of surveyed COVID-19 patients.

Characteristics All respondents HCWs
N Percentage (%) N Percentage (%)
Gender
Male 163 35.43 38 20.32
Female 297 64.57 149 79.68
Age, year
≤17 79 17.17 32 17.11
18~44 222 48.26 129 68.98
≥45 159 34.57 26 13.91
Education level
Senior high school or below 161 35 26 13.9
Above Senior high school 299 65 161 86.1
Marital status
Unmarried 100 21.74 61 32.62
Married 319 69.35 118 63.1
Divorce or windowed 41 8.91 8 4.28
Dwelling state
Live alone 84 18.26 47 25.13
Live together 376 81.74 140 74.87
Concomitant disease
No 325 70.65 158 84.49
Yes 135 29.35 29 15.51
Nucleic acid test
Positive 175 38.04 57 30.48
Negative 285 61.96 130 69.52
Fever
Yes 411 89.35 171 91.44
No 49 10.65 16 8.56
Need oxygen inhalation
No 339 73.7 150 80.21
Yes 121 26.3 37 19.79
Family members’ infection
Confirmed infection 134 29.13 30 16.04
Suspected 60 13.04 22 11.77
No infection 266 57.83 135 72.19
Psychological counseling
No 352 76.52 141 75.4
Yes 108 23.48 46 24.6
Suicidal ideation
No 353 76.74 148 79.14
Yes 107 23.26 39 20.86
Depression
No 214 46.52 90 48.13
Yes 246 53.48 97 51.87
Anxiety
No 247 53.7 103 55.08
Yes 213 46.3 84 44.92
Somatization symptoms
No 156 33.91 62 33.16
Yes 304 66.09 125 66.84
Stress response
No 350 86 133 87.5
Yes 57 14 19 12.5
Insomnia
No 236 57.99 97 63.82
Yes 171 42.01 55 36.18
Open in a new tab

HCWs healthcare works.

Fig. 1. Distribution and severity of various psychological problems in COVID-19 patients.

Fig. 1

Open in a new tab

Y axis is the names of each kind of mental problems. X axis shows the percentage.

We did the multiple logistic regression analysis to explore the risk factors related to psychological problems in COVID-19 patients. (Table 2 and Supplementary Table S1–S6) Female COVID-19 patient individuals reported a higher incidence of in somatization symptoms (odds ratio [OR], 2.54; 95% confidence interval [95% CI], 1.77–3.63 [P < 0.001]), insomnia (OR, 1.49; 95% CI, 1.07–2.09 [P = 0.019]), anxiety (OR, 1.64; 95% CI, 1.21–2.23 [P = 0.001]), suicidal ideation (OR, 1.97; 95% CI, 1.17–3.32 [P = 0.011]), stress response (OR, 3.67; 95% CI, 1.65–8.15 [P = 0.001]), and depression (OR, 2.17; 95% CI, 1.48–3.18 [P < 0.001]) than male patients. Those who had undergone divorce or bereavement reported higher rate of somatization symptoms (OR, 2.87; 95% CI, 1.49–5.52 [P = 0.002]), insomnia (OR, 2.02; 95% CI, 1.10–3.71 [P = 0.023]), anxiety (OR, 2.97; 95% CI, 1.70–5.20 [P < 0.001]), suicidal ideation (OR, 3.71; 95% CI, 1.52–9.01 [P = 0.004]), stress response (OR, 3.94; 95% CI, 1.33–11.67 [P = 0.013]), and depression (OR, 3.60; 95% CI, 1.79–7.25 [P < 0.001]) than those who were unmarried. Those who were married had more somatic symptoms (OR, 1.67; 95% CI, 1.11–2.52 [P = 0.014]), anxiety (OR, 2.26; 95% CI, 1.49–3.43 [P < 0.001]), and depression (OR, 1.95; 95% CI, 1.24–3.07 [P = 0.004]) compared with those single individuals. Patients with lower education levels tended to have higher incidence of self-mutilating or suicidal thoughts (OR, 2.68; 95% CI, 1.66–4.33 [P < 0.001]) and lower stress response (OR, 0.51; 95% CI, 0.26–1.00 [P = 0.049]). Notably, we found that, over all, patients who had fever tend to have a higher incidence of self-mutilating or suicidal thoughts (OR, 3.97; 95% CI, 2.07–7.63 [P < 0.001]), somatic symptoms (OR, 2.06; 95% CI, 1.20–3.55 [P = 0.009]), and insomnia (OR, 1.66; 95% CI, 1.04–2.65 [P = 0.033]). Those who had family members suspected as infected displayed a much higher level of anxiety than those without infected family members (OR, 1.61; 95% CI, 1.10–2.37 [P = 0.015]). In addition, patients at the age of 18–44 had more somatic symptoms in comparison with the patients >45 years old (OR, 1.91; 95% CI, 1.30–2.81 [P = 0.001]). And patients no >17 years old had less insomnia in comparison with the patients >45 years old (OR, 0.42; 95% CI, 0.25–0.70 [P = 0.001]) (Table 2).

Table 2.

Factors associated with psychological problems in COVID-19 patients.

Somatization symptoms Insomnia Anxiety Suicidal ideation Stress response Depression
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Gender
Female 2.54 (1.77–3.63) <0.001 1.49 (1.07–2.09) 0.019 1.64 (1.21–2.23) 0.001 1.97 (1.17–3.32) 0.011 3.67 (1.65–8.15) 0.001 2.17 (1.48–3.18) <0.001
Male 1 1 1 1 1 1
Marital status
Divorce/bereavement 2.87 (1.49–5.52) 0.002 2.02 (1.10–3.71) 0.023 2.97 (1.70–5.20) <0.001 3.71 (1.52–9.01) 0.004 3.94 (1.33–11.67) 0.013 3.60 (1.79–7.25) <0.001
Married 1.67 (1.11–2.52) 0.014 1.29 (0.82–2.03) 0.275 2.26 (1.49–3.43) <0.001 1.72 (0.91–3.28) 0.096 1.54 (0.70–3.37) 0.279 1.95 (1.24–3.07) 0.004
Unmarried 1 1 1 1 1 1
Psychological counseling
Yes 1.60 (1.10–2.33) 0.013 1.73 (1.20–2.49) 0.003 1.87 (1.38–2.52) <0.001 1.81 (1.07–3.05) 0.026 4.64 (2.40–9.01) <0.001 1.74 (1.15–2.62) 0.008
No 1 1 1 1 1 1
Need oxygen inhalation
Yes 2.61 (1.73–3.94) <0.001 1.50 (1.04–2.15) 0.029 1.69 (1.25–2.27) 0.001 _ _ _ _ 2.60 (1.74–3.87) <0.001
No 1 1 1 _ _ _ _ 1
Fever
Yes 2.06 (1.20–3.55) 0.009 1.66 (1.04–2.65) 0.033 _ _ 3.97 (2.07–7.63) <0.001 _ _ _ _
No 1 1 _ _ 1 _ _ _ _
Education level
Senior high school or below _ _ _ _ _ _ 2.68 (1.66–4.33) <0.001 0.51 (0.26–1.00) 0.049 _ _
Above senior high _ _ _ _ _ _ 1 1 _ _
Age, year
≤17 1.26 (0.77–2.04) 0.356 0.42 (0.25–0.70) 0.001 _ _ _ _ _ _ _ _
18–44 1.91 (1.30–2.81) 0.001 0.71 (0.50–1.00) 0.051 _ _ _ _ _ _ _ _
≥45 1 1 _ _ _ _ _ _ _ _
Family members’ infection
Confirmed infection _ _ _ _ 1.15 (0.84–1.58) 0.381 _ _ _ _ _ _
Suspected _ _ _ _ 1.61 (1.10–2.37) 0.015 _ _ _ _ _ _
No infection _ _ _ _ 1 _ _ _ _ _ _
Concomitant disease
Yes 1.82 (1.26–2.62) 0.002 _ _ _ _ _ _ _ _ _ _
No 1 _ _ _ _ _ _ _ _ _ _
Open in a new tab

The result of the multiple logistic regression analysis of HCWs is presented in Table 3. Female HCWs also reported a higher incidence of somatization symptoms (OR, 2.46; 95% CI, 1.09–5.59 [P < 0.001]) than males. Lower education levels tended to have more suicidal ideation (OR, 4.81; 95% CI, 1.41–16.43 [P < 0.001]). Those who were unmarried reported a lower rate of suicidal ideation (OR, 0.05; 95% CI, 0.01–0.40 [P = 0.005]), insomnia (OR, 0.03; 95% CI, 0.001–0.48 [P = 0.014]), and anxiety (OR, 0.06; 95% CI, 0.01–0.64 [P = 0.020]) than those who had undergone divorce or bereavement. And those who were married had less suicidal ideation (OR, 0.09; 95% CI, 0.02–0.59 [P = 0.012]), and insomnia (OR, 0.05; 95% CI, 0.003–0.68 [P = 0.025]) than those who had undergone divorce or bereavement. The HCWs who required oxygen inhalations had more anxiety (OR,10.20; 95% CI, 3.10–33.33 [P < 0.001]), somatization symptoms (OR, 8.2; 95% CI, 1.65–40.00 [P < 0.010]), insomnia (OR,16.95; 95% CI, 3.8–90.91 [P = 0.001]), and depression (OR, 5.41; 95% CI, 1.79–16.39 [P < 0.001]) than the others. Those who need psychological counseling reported a higher incidence of somatization symptoms (OR, 3.44; 95% CI, 1.26–9.35 [P = 0.016]), insomnia (OR, 5.44; 95% CI, 1.66–17.86 [P = 0.006]), and anxiety (OR, 1.33; 95% CI, 1.09–6.33 [P = 0.032]).

Table 3.

Factors associated with psychological problems in COVID-19 HCWs.

Somatization symptoms Insomnia Anxiety Suicidal ideation Stress response Depression
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Gender
Female 2.46 (1.09–5.59) 0.031 1.19 (0.47–3.03) 0.709 1.14 (0.49–2.65) 0.763 1.08 (0.39–2.96) 0.881 0.98 (0.28–3.47) 0.971 1.54 (0.71–3.33) 0.275
Male 1 1 1 1 1 1
Age, year
<35 1.76 (0.56–5.54) 0.330 3.12 (0.72–13.50) 0.127 2.37 (0.72–7.84) 0.157 0.96 (0.27–3.49) 0.954 4.86 (0.35–68.38) 0.240 2.72 (0.90–8.21) 0.076
35–45 1.63 (0.48–5.52) 0.431 1.70 (0.38–7.55) 0.483 1.11 (0.31–3.93) 0.871 0.57 (0.14–2.38) 0.438 3.53 (0.25–50.10) 0.348 1.31 (0.41–4.13) 0.645
>45 1 1 1 1 1 1
Education level
Senior high school or below 0.30 (0.09–1.00) 0.049 0.64 (0.14–2.89) 0.556 0.39 (0.09–1.60) 0.187 4.81 (1.41–16.43) 0.013 0.073 (0.01–0.93) 0.044 0.48 (0.15–1.51) 0.210
Above senior high 1 1 1 1 1 1
Marital status
Unmarried 0.21 (0.02–2.64) 0.228 0.03 (0.001–0.48) 0.014 0.06 (0.01–0.64) 0.020 0.05 (0.01–0.40) 0.005 0.80 (0.03–21.38) 0.890 0.16 (0.02–1.26) 0.082
Married 0.22 (0.02–2.46) 0.219 0.05 (0.003–0.68) 0.025 0.23 (0.03–1.90) 0.171 0.09 (0.02–0.59) 0.012 0.86 (0.05–16.20) 0.921 0.30 (0.05–2.01) 0.214
Divorce/bereavement 1 1 1 1 1 1
Dwelling state
Live alone 0.73 (0.28–1.90) 0.512 1.01 (0.34–3.00) 0.984 0.67 (0.24–1.82) 0.427 0.80 (0.25–2.54) 0.703 2.97 (0.79–11.11) 0.105 0.68 (0.29–1.64) 0.394
Live together 1 1 1 1 1 1
Concomitant disease
No 1.56 (0.54–4.53) 0.410 2.84 (0.77–10.46) 0.116 3.11 (0.95–10.24) 0.061 2.10 (0.57–7.72) 0.265 0.74 (0.15–3.65) 0.704 1.19 (0.45–3.14) 0.727
Yes 1 1 1 1 1 1
Nucleic acid test
Nucleic acid positive 1.38 (0.62–3.07) 0.43 1.37 (0.57–3.32) 0.479 0.91 (0.41–2.01) 0.807 0.65 (0.25–1.66) 0.363 0.80 (0.23–2.78) 0.721 1.425 (0.69–2.92) 0.345
Nucleic acid negative 1 1 1 1 1 1
Fever
Yes 2.59 (0.20–33.33) 0.463 0.20 (0.02–1.76) 0.144 1.06 (0.19–6.02) 0.944 0.97 (0.19–4.90) 0.973 0.86 (0.07–10.99) 0.909 1.15 (0.23–5.88) 0.866
No 1 1 1 1 1 1
Need oxygen inhalation
Yes 8.20 (1.65–40.00) 0.010 16.95 (3.18–90.91) 0.001 10.20 (3.10–33.33) <0.001 2.44 (0.83–7.14) 0.104 4.33 (0.91–20.41) 0.065 5.41 (1.79–16.39) 0.003
No 1 1 1 1 1 1
Family members’ infection
Confirmed infection 1.01 (0.33–3.10) 0.986 0.48 (0.14–1.72) 0.257 2.21 (0.74–6.58) 0.154 1.22 (0.40–3.73) 0.730 2.66 (0.65–10.95) 0.173 1.11 (0.41–3.01) 0.839
Suspected 0.68 (0.22–2.15) 0.515 1.82 (0.50–6.63) 0.363 3.03 (0.99–9.28) 0.053 0.99 (0.26–3.60) 0.982 0.44 (0.04–4.47) 0.482 1.50 (0.52–4.31) 0.455
No infection 1 1 1 1 1 1
Psychological counseling
Yes 3.44 (1.26–9.35) 0.016 5.44 (1.66–17.86) 0.006 2.63 (1.09–6.33) 0.032 1.33 (0.52–3.39) 0.552 2.29 (0.63–8.33) 0.206 1.88 (0.85–4.18) 0.118
No 1 1 1 1 1 1
Open in a new tab

Discussion

The COVID-19 pandemic is now a global health crisis and societal emergency31,32. A rapid escalation of COVID-19 cases and deaths had been reported in the world33–35. Until now, >72 million people had been infected. The appearance and continuation of these dire situations may lead to serial psychological problems in society, especially for patients who were isolated for infection. Our study demonstrated that the incidence rate of depression, anxiety, sleeping disorders, and physical disorders of COVID-19 patients was 49.05%, 56.60%, 67.92%, 69.80%, respectively, all of which were significantly higher than those of the general population. Comparing with a longitudinal study, the prevalence of anxiety and depression in the general population accounted for 28.8% and 16.5%, respectively. Although the levels of stress, anxiety, and depression have remained stable in the face of the explosion of infection cases and no clinical evidence of the reduction in the psychological impact on the general population either36. Another study revealed the worst situation among the psychiatric patients, the incidence of physical symptoms in patients with mental illness was 30.3%, and the negative psychological impacts on this group higher either29. Our results indicated that more than half of the COVID-patients had psychological problems, accounting for >80,000 people worldwide at the moment, and this number would very likely soar in the following weeks. More strikingly, nearly one-fourth of the COVID-19 patients had at one point intended to conduct self-mutilation or suicide, and 28.3% had asked for psychological counseling. These findings address the importance of paying additional attention to these psychiatric morbidities when treating the physical problems in COIVD-19 patients.

When treating COVID-19 patients, we must not ignore the subsequent complications induced by psychiatric problems. Studies have shown that psychological stress can affect the immune system through neuroendocrine pathways37,38. IL-1β, TNF-α, IL-17, IL-6, and sIL-2R in the plasma and brain of patients with chronic depression are elevated, among which IL-1β is the main inflammatory cytokine of chronic stress response39,40. Anxiety can change the response of the sympathetic nervous system, which will result in the rise of systemic arterial pressure, increasing the heart rate41,42. An excessively fast heart rate will increase the left ventricular afterload and aggravate pulmonary edema, which will ultimately affect the respiratory functions of COVID-19 patients.

In addition, emotional and somatization symptoms not only affect the current rehabilitation process of the patients but also have certain impacts on the prognosis of the disease43,44. Psychological studies on Ebola patients have confirmed that psychological stress can persist during treatment and rehabilitation45,46. Anxiety, depression, and physical symptoms can also progress into chronic psychological problems. In the long run, these acute psychological problems would finally develop into chronic mental disorders, and even PTSD47. These mental disorders may be relieved by cognitive behavioral therapy, which was effective in reducing bad coping behaviors such as avoidance, confrontation, and self-blame by enhancing the patients’ ability to manage stress48.

Therefore, screening the concomitant psychological problems and providing mental health treatments for COVID-19 patients during their hospitalization is crucial, which could reduce the frequency of the patients revisiting doctors owing to emotional or somatization symptoms after discharge. Well-implemented, this additional screening may even reduce the wastes of medical resources and minimize medical disputes as well.

Several factors have possibly contributed to the psychiatric morbidities. Patients were facing a highly infectious novel virus that would lead to an imminent threat to their physical health. Compared with other disasters, the nature of this disease was totally unpredictable because COVID-19 was an unprecedented virus. Our results presented that the incidence of psychological problems was of high similarity between infected HCWs and non-HCWs, making it possible to draw an indication that all the people, with no exceptions, would fall into panic without the proper and sufficient preparations to combat this fatal, infectious disease. The extremely high mortality rate of the COVID-19 in the early stage may have been conducive to the high incidence of psychological problems in COVID-19 patients. Furthermore, the long incubation period and highly infectious nature of this disease make it prone to induce familial cluster infection. The fears of cross-infection to their family and friends may deteriorate their psychological well-being. Finally, increased quarantining was found to be significantly predictive of persistent depressive symptoms. Patients with isolation treatment would experience a longer period of not being able to have contact with their family members, as well as many other social supports.

Further analysis revealed that the depression and somatization symptoms of married patients were more severe when compared to unmarried patients. The primary means of SARS-CoV2 transmission is through respiratory droplets and direct contact as well as some unknown means49. The difference in the intensity level of the psychological symptoms of married patients may be related to the fear of transmitting to other family members. In addition, patients with positive nucleic acid tests have more severe depression. Patients who required oxygen inhalation developed more severe somatization symptoms. These several observations suggest that patients with severe illness are more prone to various psychological symptoms like somatization and depression. In conclusion, we should pay special attention to the mental health status of female married patients, patients who are nucleic acid-positive, and severe type individuals as we provide treatments to the COVID-19 patients.

The findings of this study have several limitations. One source of limitation is due to the exclusion of patients who were in critical conditions as a matter of ethics issues. This exclusion of partial population may have resulted in selective bias. Nevertheless, we found that the severity of psychological problems demonstrated a positive relationship with the severity of diseases for all the patients. In this case, the incidence of psychological problems could have been underestimated. A second limitation is due to the nature of this cross-sectional study: the basic mental health conditions of all patients could not be evaluated. Third, the mental health condition of COVID-19 patients could have also been affected by treatments, which is an aspect we have not investigated in the survey. Therefore, some of our findings need to be interpreted with a cautious mind.

Conclusions

In summary, COVID-19 patients displayed a high incidence of anxiety, depression, and somatization. Early identification and intervention of the psychological problems in COVID-19 patients should be adopted to avoid extreme events such as self-mutilating or suicidal impulsivity of the patients, especially for those with low education levels and those females who have undergone divorce or bereavement.

Supplementary information

Supplementary Materials (43.5KB, docx)

Acknowledgements

We thank all COVID-19 patients who participated in this survey. The study was supported by the Fundamental Research Funds for the Central Universities (2020kfyXGYJ002).

Author contributions

Y.Y. designed this research. M.W., C.H., Q.Z., Q.W., H.C., Z.G., K.X., W.L., C.G., S.Z., C.C., C.Z., H.W., Y.C., L.M., P.Z., J.C., and S.H. collected the data. M.W., C.H., Q.Z. analyzed data. M.W., Y.F., and Y.Y. wrote the manuscript. All authors read and approved the final manuscript.

Data availability

All data generated or analyzed during this study are included in this published article.

Ethics approval and consent to participate

The study was approved by the institutional ethics board of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (ID: TJ-IRB20200101).

Conflict of interest

The authors declare that they have no conflict of interest.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

The online version contains supplementary material available at 10.1038/s41398-021-01259-0.

References

  • 1.Hui DS, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J. Infect. Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Paules, C.I., Marston, H.D. & Fauci, A.S. Coronavirus infections-more than just the common cold. JAMA, 323, 707–708 (2020). [DOI] [PubMed]
  • 3.Lu, H., Stratton, C.W. & Tang, Y.W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. 92, 401–402 (2020). [DOI] [PMC free article] [PubMed]
  • 4.Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ma-Lauer Y, et al. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication. Antivir. Res. 2020;173:104620. doi: 10.1016/j.antiviral.2019.104620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mahase E. Covid-19: UK holds off closing schools and restricts testing to people in hospital. BMJ. 2020;368:1060. doi: 10.1136/bmj.m1060. [DOI] [PubMed] [Google Scholar]
  • 7.Mo, P. et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin. Infect. Dis.10.1093/cid/ciaa270 (2020).
  • 8.Wang, T. et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet395, e52 (2020). [DOI] [PMC free article] [PubMed]
  • 9.Baden, L.R. & Rubin, E.J. Covid-19—the search for effective therapy. N. Engl. J. Med. 382, 1851–1852 (2020). [DOI] [PMC free article] [PubMed]
  • 10.Asmundson GJG, Taylor S. How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know. J. Anxiety Disord. 2020;71:102211. doi: 10.1016/j.janxdis.2020.102211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wang C, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) Epidemic among the General Population in China. Int J. Environ. Res. Public Health. 2020;17:1729. doi: 10.3390/ijerph17051729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ran, L. et al. Risk factors of healthcare workers with corona virus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China. Clin. Infect. Dis.71, 2218–2221 (2020). [DOI] [PMC free article] [PubMed]
  • 13.Chew NWS, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav. Immun. 2020;88:559–565. doi: 10.1016/j.bbi.2020.04.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA323, 1061–1069 (2020). [DOI] [PMC free article] [PubMed]
  • 15.Tan BYQ, et al. Psychological impact of the COVID-19 pandemic on health care workers in Singapore. Ann. Intern. Med. 2020;173:317–320. doi: 10.7326/M20-1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kwek SK, et al. Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge. J. Psychosom. Res. 2006;60:513–519. doi: 10.1016/j.jpsychores.2005.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sim K, Chong PN, Chan YH, Soon WS. Severe acute respiratory syndrome-related psychiatric and posttraumatic morbidities and coping responses in medical staff within a primary health care setting in Singapore. J. Clin. Psychiatry. 2004;65:1120–1127. doi: 10.4088/JCP.v65n0815. [DOI] [PubMed] [Google Scholar]
  • 18.Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet395, 1054–1062 (2020). [DOI] [PMC free article] [PubMed]
  • 19.Tang, B. et al. The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China. Int. J. Infect. Dis.95, 288–293 (2020). [DOI] [PMC free article] [PubMed]
  • 20.Hellewell, J. et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob. Health8, e488–e496 (2020). [DOI] [PMC free article] [PubMed]
  • 21.Tran, B.X. et al. Studies of novel Coronavirus Disease 19 (COVID-19) pandemic: a global analysis of literature. Int. J. Environ. Res. Public Health17, 4095 (2020). [DOI] [PMC free article] [PubMed]
  • 22.WHO/2019-nCoV/clinical/2020.4. [Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected].
  • 23.Levis, B., Benedetti, A. & Thombs, B.D. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ365, 1476 (2019). [DOI] [PMC free article] [PubMed]
  • 24.Kroenke, K; Spitzer, R.L.; Williams, J.B.W. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med.16, 606–613 (2001). [DOI] [PMC free article] [PubMed]
  • 25.Löwe, B. et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. J. Med. Care.46, 266–274 (2008). [DOI] [PubMed]
  • 26.Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom. Med. 2002;64:258–266. doi: 10.1097/00006842-200203000-00008. [DOI] [PubMed] [Google Scholar]
  • 27.Bastien CH, Vallières A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. J. Sleep. Med. 2001;2:297–307. doi: 10.1016/S1389-9457(00)00065-4. [DOI] [PubMed] [Google Scholar]
  • 28.Tan W, et al. Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforce. Brain Behav. Immun. 2020;87:84–92. doi: 10.1016/j.bbi.2020.04.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hao F, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav. Immun. 2020;87:100–106. doi: 10.1016/j.bbi.2020.04.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Naa PeterJ, et al. The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)-9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS) J. Affect. Disord. 2018;232:34–40. doi: 10.1016/j.jad.2018.02.045. [DOI] [PubMed] [Google Scholar]
  • 31.Ebrahim SH, Ahmed QA, Gozzer E, Schlagenhauf P, Memish ZA. Covid-19 and community mitigation strategies in a pandemic. BMJ. 2020;368:m1066. doi: 10.1136/bmj.m1066. [DOI] [PubMed] [Google Scholar]
  • 32.Bedford, J. et al. COVID-19: towards controlling of a pandemic. Lancet395, 1015–1018 (2020). [DOI] [PMC free article] [PubMed]
  • 33.Hopman, J., Allegranzi, B. & Mehtar, S. Managing COVID-19 in Low- and Middle-Income Countries. JAMA323, 1549–1550 (2020). [DOI] [PubMed]
  • 34.Elkind, M.S., Harrington, R.A. & Benjamin, I.J. Role of the American Heart Association in the global COVID-19 pandemic. Circulation141, e743–e745 (2020). [DOI] [PMC free article] [PubMed]
  • 35.Adams, J.G. & Walls, R.M. Supporting the health care workforce during the COVID-19 global epidemic. JAMA323, 1439–1440 (2020). [DOI] [PubMed]
  • 36.Wang C, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav. Immun. 2020;87:40–48. doi: 10.1016/j.bbi.2020.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.de Punder K, Heim C, Wadhwa PD, Entringer S. Stress and immunosenescence: the role of telomerase. Nat. Med. 2019;101:87–100. doi: 10.1016/j.psyneuen.2018.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yang H, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat. Med. 2019;25:1428–1441. doi: 10.1038/s41591-019-0566-4. [DOI] [PubMed] [Google Scholar]
  • 39.Lu Y, et al. Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression. PLoS ONE. 2017;12:e0186700. doi: 10.1371/journal.pone.0186700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 2012;139:230–239. doi: 10.1016/j.jad.2011.08.003. [DOI] [PubMed] [Google Scholar]
  • 41.Mizuno T, Tamakoshi K, Tanabe K. Anxiety during pregnancy and autonomic nervous system activity: a longitudinal observational and cross-sectional study. J. Clin. Med. 2017;99:105–111. doi: 10.1016/j.jpsychores.2017.06.006. [DOI] [PubMed] [Google Scholar]
  • 42.Zou, L., Sasaki, J.E., Wei, G.X. & Huang, T. Effects of mind(-)body exercises (Tai Chi/Yoga) on heart rate variability parameters and perceived stress: a systematic review with meta-analysis of randomized controlled trials. J. Clin. Med.7, 404 (2018). [DOI] [PMC free article] [PubMed]
  • 43.Reijnders T, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respir. Med. 2019;146:87–95. doi: 10.1016/j.rmed.2018.12.004. [DOI] [PubMed] [Google Scholar]
  • 44.Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J. Chron. Obstruct. Pulmon. Dis. 2014;9:1289–1306. doi: 10.2147/COPD.S72073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Reardon S. Ebola’s mental-health wounds linger in Africa. Nature. 2015;519:13–14. doi: 10.1038/519013a. [DOI] [PubMed] [Google Scholar]
  • 46.Park SJ, Akello G. The oughtness of care: fear, stress, and caregiving during the 2000-2001 Ebola outbreak in Gulu, Uganda. Soc. Sci. Med. 2017;194:60–66. doi: 10.1016/j.socscimed.2017.10.010. [DOI] [PubMed] [Google Scholar]
  • 47.Mak IW, et al. Risk factors for chronic post-traumatic stress disorder (PTSD) in SARS survivors. Gen. Hosp. Psychiatry. 2010;32:590–598. doi: 10.1016/j.genhosppsych.2010.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann. Acad. Med. Singap. 2020;49:155–160. doi: 10.47102/annals-acadmedsg.202043. [DOI] [PubMed] [Google Scholar]
  • 49.Peng X, et al. Transmission routes of 2019-nCoV and controls in dental practice. Int. J. Oral. Sci. 2020;12:9. doi: 10.1038/s41368-020-0075-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials (43.5KB, docx)

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Articles from Translational Psychiatry are provided here courtesy of Nature Publishing Group

RESOURCES